GSK3B and type 2 diabetes mellitus: In agreement with the present results, a study conducted by Sun et al. (2020) has demonstrated that HFD/STZ‐induced type 2 diabetes could increase the activity of GSK‐3β, resulting in enhanced accumulation of Fyn in the cell nucleus (Yi et al., 2018).